Sodium-dependent methotrexate carrier-1 is expressed in rat kidney: Cloning and functional characterization

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Kneuer, Carsten ^a   Honscha, Kerstin U ^a   Honscha, Walther ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Drug elimination; Nephrotoxicity; Renal organic anion transporter

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ACETYLSALICYLIC ACID; BILE ACID; BUMETANIDE; CARRIER PROTEIN; CHOLIC ACID; COMPLEMENTARY DNA; DIHYDROFOLIC ACID; FOLIC ACID; METHOTREXATE; OUABAIN; PROTEIN RK MTX 1; SODIUM DEPENDENT METHOTREXATE CARRIER 1; TAUROCHOLIC ACID; TETRAHYDROFOLIC ACID; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG ELIMINATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KIDNEY; MOLECULAR CLONING; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT;

EID: 1242351766     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00257.2003     Document Type: Article

References (48)

1. Bakos E, Evers R, Sinko E, Varadi A, Borst P, and Sarkadi B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol 57: 760-768, 2000.
2. Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, and Klaassen CD. Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 301: 145-151, 2002.
3. Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, and Endou H. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275: 4507-4512, 2000.
4. Chen ZS, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, and Kruh GD. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res 62: 3144-3150, 2002.
5. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Delepine N, Delepine G, Cornille H, Brion F, Arnaud P, and Desbois JC. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma. Anticancer Res 15: 489-494, 1995.
7. Drori S, Jansen G, Mauritz R, Peters GJ, and Assaraf YG. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake. J Biol Chem 275: 30855-30863, 2000.
8. Erickson AR, Reddy V, Vogelsang SA, and West SG. Usefulness of the American college of rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Arthritis Rheum 38: 1115-1119, 1995.
9. Fleck C, Hilger R, Jurkutat S, Karge E, Merkel U, Schimske A, and Schubert J. Ex vivo stimulation of renal transport of the cytostatic drugs methotrexate, cisplatin, topotecan (Hycamtin) and ralitrexed (Tomudex) by dexamethasone, T3 and EGF in intact human and rat kidney tissue and in human renal cell carcinoma. Urol Res 30: 256-262, 2002.
10. Gewirtz DA, White JC, Randolph JK, and Goldman ID. Transport, binding, and polyglutamation of methotrexate in freshly isolated rat hepatocytes. Cancer Res 40: 573-578, 1980.
11. +/bile acid cotransport system. Proc Natl Acad Sci USA 88: 10629-10633, 1991.
12. +/glucose co-transporter. Nature 330: 379-381, 1987.
13. Honscha W, Dötsch KU, Thomsen N, and Petzinger E. Cloning and functional characterization of the bile acid-sensitive methotrexate carrier from rat liver cells. Hepatology 31: 1296-1304, 2000.
14. Honscha W and Petzinger E. Characterization of the bile acid sensitive methotrexate carrier of rat liver cells. Naunyn Schmiedebergs Arch Pharmacol 359: 411-419, 1999.
15. Honscha W, Platte HD, Oesch F, and Friedberg T. Relationship between the microsomal epoxide hydrolase and the hepatocellular transport of bile acids and xenobiotics. Biochem J 311: 975-979, 1995.
16. + and pH dependence of 5-methyltetrahydrofolic acid and methotrexate transport in freshly isolated hepatocytes. Biochim Biophys Acta 1023: 47-53, 1990.
17. Horne DW and Reed KA. Transport of methotrexate in basolateral membrane vesicles from rat liver. Arch Biochem Biophys 298: 121-128, 1992.
18. Iqbal MP. Accumulation of methotrexate in human tissues following high-dose methotrexate therapy. J Pak Med Assoc 48: 341-343, 1998.
19. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, and Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med 309: 1094-1104, 1983.
20. Kinoshita A, Kurosawa Y, Kondoh K, Suzuki T, Manabe A, Inukai T, Sugita K, and Nakazawa S. Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 31: 256-260, 2003.
21. Koch Nogueira PC, Hadj-Aïssa A, Schell M, Dubourg L, Brunat-Mentigny M, and Cochat P. Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma. Pediatr Nephrol 12: 572-575, 1998.
22. König J, Cui Y, Nies A, and Keppler D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem 275: 23161-23168, 2000.
23. Kremer JM, Kaye GI, Kaye NW, Ishak KG, and Axiotis CA. Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis Rheum 38: 1194-1203, 1995.
24. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, and Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120: 525-533, 2001.
25. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, and Endou H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274: 13675-13680, 1999.
26. Masuda S, Ibaramoto K, Takeuchi A, Saito H, Hashimoto Y, and Inui KI. Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney. Mol Pharmacol 55: 743-753, 1999.
27. Masuda S, Saito H, Nonoguchi H, Tomita K, and Inui KI. mRNA distribution and membrane localization of the OAT-K1 organic anion transporter in rat renal tubules. FEBS Lett 407: 127-131, 1997.
28. McAteer JA, Evan AP, and Gardner KD. Morphogenetic growth of kidney epithelial cell line MDCK. Anat Rec 217: 229-239, 1987.
29. Nguyen TT, Dyer DL, Dunning DD, Rubin SA, Grant KE, and Said HM. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology 112: 783-791, 1997.
30. Roy K, Tolner B, Chiao JH, and Sirotnak FM. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells. J Biol Chem 273: 2526-2531, 1998.
31. Saito H, Masuda S, and Inui KI. Cloning and functional characterization of a novel rat organic anion transporter mediating uptake of methotrexate in the kidney. J Biol Chem 271: 20719-20725, 1996.
32. Schaub TP, Kartenbeck J, Konig J, Spring H, Dorsam J, Staehler G, Storkel S, Thon WF, and Keppler D. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 10: 1159-1169, 1999.
33. Schornagel JH, Verweij J, de Mulder PHM, Cognetti F, Vermorken JB, Cappelaere P, Armand JP, Wildiers J, de Graeff A, Clavel M, Sahmoud T, Kirkpatrick A, and Lefebvre JL. Randomized phase III trial of edatrexate vs. methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European organization for research and treatment of cancer head and neck cancer cooperative group study. J Clin Oncol 13: 1649-1655, 1995.
34. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, and Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272: 18526-18529, 1997.
35. Sharina IG, Zhao R, Wang Y, Babani S, and Goldman ID. Mutational analysis of the functional role of conserved arginine and lysine residues in transmembrane domains of the murine reduced folate carrier. Mol Pharmacol 59: 1022-1028, 2001.
36. Simmons NL, Hunter J, and Jepson MA. Targeted delivery of a substrate for P-glycoprotein to renal cysts in vitro. Biochim Biophys Acta 1237: 31-36, 1995.
37. Simonson GD, Vincent AC, Roberg KJ, Huang Y, and Iwanij V. Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci 107: 1065-1072, 1994.
38. St.-Pierre MV, Kullak-Ublick GA, Hagenbuch B, and Meier PJ. Transport of bile acids in hepatic and non-hepatic tissues. J Exp Biol 204: 1673-1686, 2001.
39. Sweet DH, Wolff NA, and Pritchard JB. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 272: 30088-30095, 1997.
40. Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, and Endou H. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther 302: 666-671, 2002.
41. Van Aubel RAMH, Smeets PHE, Peters JGP, Bindels RJM, and Russel FGM. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 13: 595-603, 2002.
42. Wall SM, Johansen MJ, Molony DA, DuBose TD Jr, Jaffe N, and Madden T. Effective clearance of methotrexate using high-flux hemodialysis membrane. Am J Kidney Dis 28: 846-854, 1996.
43. Wang Y, Zhao R, Russell RG, and Goldman ID. Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis. Biochim Biophys Acta 1513: 49-54, 2001.
44. Whetstine JR, Flatley RM, and Matherly LH. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem J 367: 629-640, 2002.
45. Williams FM, Murray RC, Underhill TM, and Flintoff WF. Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J Biol Chem 269: 5810-5816, 1994.
46. Wong MH, Oelkers PM, Craddock AL, and Dawson PA. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. Biol Chem 269: 1340-1347, 1994.
47. Zhao R, Gao F, Wang PJ, and Goldman ID. Role of the amino acid 45 residue in reduced folate carrier function and ion-dependent transport as characterized by site-directed mutagenesis. Mol Pharmacol 57: 317-323, 2000.
48. Zhao R, Sharina IG, and Goldman ID. Pattern of mutations that results in loss of reduced folate carrier function under antifolate selective pressure augmented by chemical mutagenesis. Mol Pharmacol 56: 68-76, 1999.